Tolvaptan is a racemic compound consisting of equal amounts of (R)- and (S)-tolvaptan. It acts as a selective vasopressin V2 receptor antagonist and is used in the management of certain types of hyponatremia and to slow the progression of kidney disease in autosomal dominant polycystic kidney disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150683-30-0
Tolvaptan sodium phosphate
pharmaceutical raw material
N-(4-(5-Hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
research compound
Oxybutynin chloride
pharmaceutical raw material
Tropicamide
pharmaceutical raw material
Procyclidine hydrochloride
pharmaceutical raw material
Ezogabine dihydrochloride
pharmaceutical raw material
Mozavaptan
pharmaceutical raw material
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
GYHCTFXIZSNGJT-UHFFFAOYSA-N
CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C